RxDoctor Payments DataLook up a doctor →

Brock Aldrich, DO

Internal Medicine · Layton, UTNPI 1497209050

Payments from drug & device makers

$14,350in general payments, 2019–2025

Across 963 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$1K
  • Amgen$1K
  • Lilly USA, LLC$845
  • Novartis$592
  • Pfizer$563
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)245$3,470
Novo Nordisk113$1,237
Amgen79$1,086
Lilly USA, LLC63$845
Novartis36$592
Pfizer31$563
Axsome Therapeutics, Inc.25$423
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC34$410
Astellas Pharma US Inc23$393
GSK23$359
AstraZeneca16$313
Otsuka America Pharmaceutical, Inc.19$312
Boehringer Ingelheim16$290
Nestle Healthcare Nutrition Inc.16$271
Sanofi-aventis U.S. LLC15$216
Johnson & Johnson(2 entities)13$216
Sumitomo Pharma America, Inc.12$193
Daiichi Sankyo Inc.11$189
Lundbeck LLC8$165
Amarin Pharma, Inc.10$157
Corium, LLC8$147
Takeda Pharmaceuticals U.S.A., Inc.7$145
E.r. Squibb & Sons, L.L.C.9$142
Idorsia Pharmaceuticals US Inc9$140
Aimmune Therapeutics, Inc.7$138
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$126
Biohaven Pharmaceutical Holding Company Ltd.8$125
Dexcom, Inc.4$120
Biogen7$109
Exact Sciences6$104
Antares Pharma, Inc.6$103
Jazz Pharmaceuticals Inc.6$93
Avanir Pharmaceuticals, Inc.5$74
Teva Pharmaceuticals USA, Inc.4$64
Biohaven Pharmaceuticals, Inc.4$63
Halozyme Inc3$55
Arbor Pharmaceuticals, Inc.3$48
Harmony Biosciences LLC3$45
Kowa Pharmaceuticals America, Inc.3$45
Lucid Diagnostics Inc.3$43
Lifescan, Inc.2$41
Neurocrine Biosciences, Inc.2$40
Merck3$39
Sunovion Pharmaceuticals Inc.3$39
Bausch Health US, LLC3$38
Stryker1$37
Bayer2$37
Redhill Biopharma Inc.2$34
Grifols USA, LLC2$34
Ardelyx, Inc.2$32
Phathom Pharmaceuticals, Inc.2$30
Corcept Therapeutics2$28
Edwards Lifesciences1$26
Insulet Corporation1$23
Ultragenyx Pharmaceutical Inc.1$19
QOL Medical, LLC1$19
Pharmacosmos Therapeutics Inc.1$18
MDD US Operations, LLC1$17
Inspire Medical Systems, Inc.1$17
Acella Pharmaceuticals, LLC1$16

How this compares

$14,350 in reported general payments places this provider in the 90th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$197,031
Medicare patients
359
Services billed
8,812

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Layton

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →